We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENFN
401
DELISTED
Enfusion, Inc.
ENFN
$942K 0.07%
84,508
-27,275
-24% -$301K
ICUI icon
402
ICU Medical
ICUI
$4.16B
$942K 0.07%
6,781
-2,821
-29% -$438K
CHKP icon
403
Check Point Software Technologies
CHKP
$14.3B
$935K 0.07%
4,104
+4
+0.1% +$848
SAGE
404
DELISTED
Sage Therapeutics
SAGE
$926K 0.07%
116,528
-118,569
-50% -$868K
ACIW icon
405
ACI Worldwide
ACIW
$6.12B
$923K 0.07%
16,868
SII
406
Sprott
SII
$2.68B
$918K 0.07%
20,470
-3,786
-16% -$163K
CVE icon
407
Cenovus Energy
CVE
$54.2B
$915K 0.07%
+65,800
New +$948K
GWRE icon
408
Guidewire Software
GWRE
$13.9B
$911K 0.06%
4,863
-638
-12% -$124K
BASE
409
DELISTED
Couchbase
BASE
$907K 0.06%
57,614
+42,484
+281% +$704K
BLCO icon
410
Bausch + Lomb
BLCO
$5.78B
$885K 0.06%
61,003
+12,228
+25% +$201K
SHAK icon
411
Shake Shack
SHAK
$2.54B
$882K 0.06%
10,000
+464
+5% +$50.4K
GIC icon
412
Global Industrial
GIC
$1.38B
$868K 0.06%
38,769
+16,169
+72% +$386K
VSTS icon
413
Vestis
VSTS
$1.97B
$868K 0.06%
87,653
-248
-0.3% -$3.29K
SNCY
414
DELISTED
Sun Country Airlines
SNCY
$865K 0.06%
70,215
-45,587
-39% -$706K
MYGN icon
415
Myriad Genetics
MYGN
$476M
$855K 0.06%
+96,434
New +$1.16M
SNEX icon
416
StoneX
SNEX
$8.72B
$853K 0.06%
25,133
-51
-0.2% -$1.71K
PDS
417
Precision Drilling
PDS
$940M
$852K 0.06%
18,276
+2,492
+16% +$136K
WS icon
418
Worthington Steel
WS
$1.78B
$845K 0.06%
+33,349
New +$940K
EE icon
419
Excelerate Energy
EE
$1.19B
$836K 0.06%
29,142
-20,784
-42% -$622K
EQX icon
420
Equinox Gold
EQX
$7.07B
$836K 0.06%
121,453
+18,290
+18% +$117K
U icon
421
Unity
U
$14B
$835K 0.06%
+42,600
New +$962K
DAC icon
422
Danaos Corp
DAC
$2.52B
$830K 0.06%
10,640
+2,644
+33% +$212K
ANAB icon
423
AnaptysBio
ANAB
$1.54B
$828K 0.06%
+44,529
New +$743K
CDE icon
424
Coeur Mining
CDE
$15.1B
$823K 0.06%
+139,033
New +$858K
SA
425
Seabridge Gold
SA
$2.72B
$822K 0.06%
70,473
+39,433
+127% +$468K

Similar funds

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.